RU2287160C2 - Количественный диагностический анализ гипертензии - Google Patents

Количественный диагностический анализ гипертензии Download PDF

Info

Publication number
RU2287160C2
RU2287160C2 RU2003130071/15A RU2003130071A RU2287160C2 RU 2287160 C2 RU2287160 C2 RU 2287160C2 RU 2003130071/15 A RU2003130071/15 A RU 2003130071/15A RU 2003130071 A RU2003130071 A RU 2003130071A RU 2287160 C2 RU2287160 C2 RU 2287160C2
Authority
RU
Russia
Prior art keywords
snp
hypertension
exon
hsgk1
gene
Prior art date
Application number
RU2003130071/15A
Other languages
English (en)
Russian (ru)
Other versions
RU2003130071A (ru
Inventor
Флориан ЛАНГ (DE)
Флориан Ланг
Андреас БУЗЯН (DE)
Андреас БУЗЯН
Фридрих ЛУФТ (DE)
Фридрих ЛУФТ
Original Assignee
Флориан Ланг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Флориан Ланг filed Critical Флориан Ланг
Publication of RU2003130071A publication Critical patent/RU2003130071A/ru
Application granted granted Critical
Publication of RU2287160C2 publication Critical patent/RU2287160C2/ru

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/723—Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
RU2003130071/15A 2001-03-21 2002-03-21 Количественный диагностический анализ гипертензии RU2287160C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10113876.8 2001-03-21
DE10113876A DE10113876A1 (de) 2001-03-21 2001-03-21 Quantitative diagnostische Analyse der Hypertonie

Publications (2)

Publication Number Publication Date
RU2003130071A RU2003130071A (ru) 2005-04-10
RU2287160C2 true RU2287160C2 (ru) 2006-11-10

Family

ID=7678460

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2003130071/15A RU2287160C2 (ru) 2001-03-21 2002-03-21 Количественный диагностический анализ гипертензии

Country Status (18)

Country Link
US (1) US20060127892A1 (el)
EP (1) EP1390531B1 (el)
JP (1) JP2004528032A (el)
CN (1) CN1306040C (el)
AT (1) ATE331043T1 (el)
AU (1) AU2002244751B2 (el)
CA (1) CA2441314C (el)
CY (1) CY1105566T1 (el)
DE (2) DE10113876A1 (el)
DK (1) DK1390531T3 (el)
ES (1) ES2266463T3 (el)
HK (1) HK1063338A1 (el)
HU (1) HUP0303491A3 (el)
MX (1) MXPA03008522A (el)
PL (1) PL364387A1 (el)
PT (1) PT1390531E (el)
RU (1) RU2287160C2 (el)
WO (1) WO2002074987A2 (el)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2436393A1 (en) * 2001-12-19 2012-04-04 Millennium Pharmaceuticals, Inc. Human diacylglycerol acyltransferase 2 (DGAT2) family members and uses therefor
US6830911B2 (en) * 2002-02-08 2004-12-14 Applera Corporation Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
DE10305213A1 (de) * 2003-02-07 2004-08-26 Florian Prof. Dr.med. Lang Verwendung eines neuen Polymorphismus im hsgk1-Gen zur Diagnose der Hypertonie und Verwendung der sgk-Genfamilie zur Diagnose und Therapie des Long-Q/T-Syndroms
EP1613766A1 (de) * 2003-03-03 2006-01-11 Florian Physiologisches Institut I Lang Sgk1 als diagnostisches und therapeutisches target
DE10346913A1 (de) 2003-10-09 2005-05-04 Merck Patent Gmbh Acylhydrazonderivate
WO2007025792A1 (de) * 2005-09-02 2007-03-08 Florian Lang Verfahren zur diagnose von hypertonie
CN102654893A (zh) * 2011-03-04 2012-09-05 苏州卫生职业技术学院 分析高尿酸血症和高血压患病率关系的方法
WO2023114714A1 (en) * 2021-12-14 2023-06-22 Arizona Board Of Regents On Behalf Of The University Of Arizona Sgk1 inhibitory compositions and methods

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19917990A1 (de) * 1999-04-20 2000-11-02 Florian Lang Arzneimittel enthaltend Hemmstoffe der zellvolumenregulierten humanen Kinase h-sgk

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
WAERNTGES S. et al., Transcriptional upregulation of the human serine-threonine Kinase hSGK1 in glomerulonephritis, Kidney and blood pressure zesearch, 2000, v.23, №3-5, seite 246. *

Also Published As

Publication number Publication date
AU2002244751C1 (en) 2002-10-03
EP1390531A2 (de) 2004-02-25
EP1390531B1 (de) 2006-06-21
US20060127892A1 (en) 2006-06-15
CA2441314A1 (en) 2002-09-26
MXPA03008522A (es) 2005-03-07
HUP0303491A3 (en) 2005-12-28
PL364387A1 (en) 2004-12-13
PT1390531E (pt) 2006-09-29
ATE331043T1 (de) 2006-07-15
CN1306040C (zh) 2007-03-21
CA2441314C (en) 2011-11-08
ES2266463T3 (es) 2007-03-01
DK1390531T3 (da) 2006-10-23
DE10113876A1 (de) 2002-09-26
CN1503848A (zh) 2004-06-09
RU2003130071A (ru) 2005-04-10
HK1063338A1 (en) 2004-12-24
WO2002074987A2 (de) 2002-09-26
CY1105566T1 (el) 2010-07-28
AU2002244751B2 (en) 2007-01-11
WO2002074987A3 (de) 2003-12-04
JP2004528032A (ja) 2004-09-16
HUP0303491A2 (hu) 2004-08-30
DE50207305D1 (de) 2006-08-03

Similar Documents

Publication Publication Date Title
Koo et al. Polymorphisms of KCNJ11 (Kir6. 2 gene) are associated with Type 2 diabetes and hypertension in the Korean population
CN111676283B (zh) 与高原肺水肿发生相关的线粒体dna单核苷酸多态性的应用
Mouton et al. MYBPH acts as modifier of cardiac hypertrophy in hypertrophic cardiomyopathy (HCM) patients
Fang et al. Association of endothelin-1 gene polymorphisms with essential hypertension in a Chinese population
Ben-Salem et al. Polymorphisms of transcription factor-7-like 2 (TCF7L2) gene in Tunisian women with polycystic ovary syndrome (PCOS)
ZA200506283B (en) Use of a novel polymorphism in the hsgk1 gene in the diagnosis of hypertonia and use of the sgk gene family in the diagnosis and therapy of the long QT syndrome
Ping et al. Effects of variation in retinol binding protein 4 gene and adipose specific expression of gestational diabetes in Beijing, China
RU2287160C2 (ru) Количественный диагностический анализ гипертензии
WO2005078128A1 (en) Method for detecting the risk of preeclampsia by analysing a dimethylarginine dimethylaminohydrolase gene
US10519507B2 (en) Method for detecting T-cell lymphoma
CN111560428A (zh) 检测线粒体DNA rs3937033单核苷酸多态性的物质的用途
Qiu et al. Genetic polymorphisms, messenger RNA expression of p53, p21, and CCND1, and possible links with chromosomal aberrations in Chinese vinyl chloride–exposed workers
Maia et al. The type 2 deiodinase (DIO2) A/G polymorphism is not associated with glycemic traits: the Framingham Heart Study
Banno et al. Association of genetic polymorphisms of endothelin-converting enzyme-1 gene with hypertension in a Japanese population and rare missense mutation in preproendothelin-1 in Japanese hypertensives
Xu et al. Renal function and klotho gene polymorphisms among Uygur and Kazak populations in Xinjiang, China
CN106661618B (zh) Dna甲基化状态作为酒精使用和戒酒的生物标志物
EP2681337B1 (en) Brip1 variants associated with risk for cancer
Kamide et al. Genetic variations of HSD11B2 in hypertensive patients and in the general population, six rare missense/frameshift mutations
KR101902512B1 (ko) Esrrg 유전자 다형성을 이용한 당뇨병의 예후 또는 위험도를 평가하는 방법 및 키트
Alsalman et al. Lack of association between the insulin receptor substrates-1 Gly972Arg polymorphism and type-2 diabetes mellitus among Saudis from Eastern Saudi Arabia
US8236497B2 (en) Methods of diagnosing cardiovascular disease
WO2010072608A1 (en) Pcsk1 single nucleotide polymorphism in type 2 diabetes
KR20190063026A (ko) 폐암 환자의 변증 구분용 snp 마커 및 이의 용도
WO2013061342A1 (en) Variants conferring risk of intracranial aneurysm and abdominal aortic aneurysm
Mackawy et al. Association of protein tyrosine phosphatase 1B (PTPN1) gene polymorphisms (1023C> A and 467T> C) with type 2 diabetes: A case-control study

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20130322